Abrysvo act-o-vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9R0W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,425
Award facts
- Contract value 100% obligated
- $1,425.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 20, 2026, with an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under full and open competition. The contractor, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen's DLA IDC enables the company to supply a broad range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and medical test kits—to support military healthcare programs worldwide. Through this contract vehicle, the company serves critical customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its established capability to efficiently fulfill government procurement requirements for essential pharmaceutical and medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9R0W?
SPE2DR26F9R0W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9R0W worth?
The government has obligated $1,425 on SPE2DR26F9R0W.
Is contract SPE2DR26F9R0W an order under another contract?
Yes. SPE2DR26F9R0W is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9R0W competed?
The extent of competition for SPE2DR26F9R0W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award